DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Predicting kinase inhibitors using bioactivity matrix derived informer sets

Abstract

Prediction of compounds that are active against a desired biological target is a common step in drug discovery efforts. Virtual screening methods seek some active-enriched fraction of a library for experimental testing. Where data are too scarce to train supervised learning models for compound prioritization, initial screening must provide the necessary data. Commonly, such an initial library is selected on the basis of chemical diversity by some pseudo-random process (for example, the first few plates of a larger library) or by selecting an entire smaller library. These approaches may not produce a sufficient number or diversity of actives. An alternative approach is to select an informer set of screening compounds on the basis of chemogenomic information from previous testing of compounds against a large number of targets. We compare different ways of using chemogenomic data to choose a small informer set of compounds based on previously measured bioactivity data. We develop this Informer-Based-Ranking (IBR) approach using the Published Kinase Inhibitor Sets (PKIS) as the chemogenomic data to select the informer sets. We test the informer compounds on a target that is not part of the chemogenomic data, then predict the activity of the remaining compounds based on the experimental informermore » data and the chemogenomic data. Through new chemical screening experiments, we demonstrate the utility of IBR strategies in a prospective test on three kinase targets not included in the PKIS.« less

Authors:
 [1]; ORCiD logo [1];  [2];  [1]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [3]; ORCiD logo [4];  [1];  [1]; ORCiD logo [1]; ORCiD logo [1];  [1]
  1. Univ. of Wisconsin, Madison, WI (United States)
  2. National Univ. of Singapore (Singapore)
  3. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  4. Univ. of Wisconsin, Madison, WI (United States); Morgridge Inst. for Research, Madison, WI (United States)
Publication Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE; National Science Foundation (NSF)
OSTI Identifier:
1559708
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
PLoS Computational Biology (Online)
Additional Journal Information:
Journal Name: PLoS Computational Biology (Online); Journal Volume: 15; Journal Issue: 8; Journal ID: ISSN 1553-7358
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Zhang, Huikun, Ericksen, Spencer S., Lee, Ching-pei, Ananiev, Gene E., Wlodarchak, Nathan, Yu, Peng, Mitchell, Julie C., Gitter, Anthony, Wright, Stephen J., Hoffmann, F. Michael, Wildman, Scott A., Newton, Michael A., and Schlessinger, Avner. Predicting kinase inhibitors using bioactivity matrix derived informer sets. United States: N. p., 2019. Web. doi:10.1371/journal.pcbi.1006813.
Zhang, Huikun, Ericksen, Spencer S., Lee, Ching-pei, Ananiev, Gene E., Wlodarchak, Nathan, Yu, Peng, Mitchell, Julie C., Gitter, Anthony, Wright, Stephen J., Hoffmann, F. Michael, Wildman, Scott A., Newton, Michael A., & Schlessinger, Avner. Predicting kinase inhibitors using bioactivity matrix derived informer sets. United States. https://doi.org/10.1371/journal.pcbi.1006813
Zhang, Huikun, Ericksen, Spencer S., Lee, Ching-pei, Ananiev, Gene E., Wlodarchak, Nathan, Yu, Peng, Mitchell, Julie C., Gitter, Anthony, Wright, Stephen J., Hoffmann, F. Michael, Wildman, Scott A., Newton, Michael A., and Schlessinger, Avner. Mon . "Predicting kinase inhibitors using bioactivity matrix derived informer sets". United States. https://doi.org/10.1371/journal.pcbi.1006813. https://www.osti.gov/servlets/purl/1559708.
@article{osti_1559708,
title = {Predicting kinase inhibitors using bioactivity matrix derived informer sets},
author = {Zhang, Huikun and Ericksen, Spencer S. and Lee, Ching-pei and Ananiev, Gene E. and Wlodarchak, Nathan and Yu, Peng and Mitchell, Julie C. and Gitter, Anthony and Wright, Stephen J. and Hoffmann, F. Michael and Wildman, Scott A. and Newton, Michael A. and Schlessinger, Avner},
abstractNote = {Prediction of compounds that are active against a desired biological target is a common step in drug discovery efforts. Virtual screening methods seek some active-enriched fraction of a library for experimental testing. Where data are too scarce to train supervised learning models for compound prioritization, initial screening must provide the necessary data. Commonly, such an initial library is selected on the basis of chemical diversity by some pseudo-random process (for example, the first few plates of a larger library) or by selecting an entire smaller library. These approaches may not produce a sufficient number or diversity of actives. An alternative approach is to select an informer set of screening compounds on the basis of chemogenomic information from previous testing of compounds against a large number of targets. We compare different ways of using chemogenomic data to choose a small informer set of compounds based on previously measured bioactivity data. We develop this Informer-Based-Ranking (IBR) approach using the Published Kinase Inhibitor Sets (PKIS) as the chemogenomic data to select the informer sets. We test the informer compounds on a target that is not part of the chemogenomic data, then predict the activity of the remaining compounds based on the experimental informer data and the chemogenomic data. Through new chemical screening experiments, we demonstrate the utility of IBR strategies in a prospective test on three kinase targets not included in the PKIS.},
doi = {10.1371/journal.pcbi.1006813},
journal = {PLoS Computational Biology (Online)},
number = 8,
volume = 15,
place = {United States},
year = {Mon Aug 05 00:00:00 EDT 2019},
month = {Mon Aug 05 00:00:00 EDT 2019}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Do Structurally Similar Molecules Have Similar Biological Activity?
journal, September 2002

  • Martin, Yvonne C.; Kofron, James L.; Traphagen, Linda M.
  • Journal of Medicinal Chemistry, Vol. 45, Issue 19
  • DOI: 10.1021/jm020155c

Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem’s Bioassay Repository
journal, January 2016

  • Helal, Kazi Yasin; Maciejewski, Mateusz; Gregori-Puigjané, Elisabet
  • Journal of Chemical Information and Modeling, Vol. 56, Issue 2
  • DOI: 10.1021/acs.jcim.5b00498

In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth
journal, September 2018


Experimental Design Strategy: Weak Reinforcement Leads to Increased Hit Rates and Enhanced Chemical Diversity
journal, May 2015

  • Maciejewski, Mateusz; Wassermann, Anne Mai; Glick, Meir
  • Journal of Chemical Information and Modeling, Vol. 55, Issue 5
  • DOI: 10.1021/acs.jcim.5b00054

Integrating virtual screening in lead discovery
journal, August 2004


Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data
journal, February 2016

  • Paricharak, Shardul; IJzerman, Adriaan P.; Bender, Andreas
  • ACS Chemical Biology, Vol. 11, Issue 5
  • DOI: 10.1021/acschembio.6b00029

PMU Placement for Line Outage Identification via Multinomial Logistic Regression
journal, January 2018


Using Information from Historical High-Throughput Screens to Predict Active Compounds
journal, June 2014

  • Riniker, Sereina; Wang, Yuan; Jenkins, Jeremy L.
  • Journal of Chemical Information and Modeling, Vol. 54, Issue 7
  • DOI: 10.1021/ci500190p

Comprehensive characterization of the Published Kinase Inhibitor Set
text, January 2016

  • A., Tropsha,; M., Kunkel,; X. -P., Huang,
  • Nature Publishing Group
  • DOI: 10.17615/fnn8-qq87

Comprehensive characterization of the Published Kinase Inhibitor Set
journal, October 2015

  • Elkins, Jonathan M.; Fedele, Vita; Szklarz, Marta
  • Nature Biotechnology, Vol. 34, Issue 1
  • DOI: 10.1038/nbt.3374

Data-Driven Derivation of an “Informer Compound Set” for Improved Selection of Active Compounds in High-Throughput Screening
journal, August 2016

  • Paricharak, Shardul; IJzerman, Adriaan P.; Jenkins, Jeremy L.
  • Journal of Chemical Information and Modeling, Vol. 56, Issue 9
  • DOI: 10.1021/acs.jcim.6b00244

Extended-Connectivity Fingerprints
journal, April 2010

  • Rogers, David; Hahn, Mathew
  • Journal of Chemical Information and Modeling, Vol. 50, Issue 5
  • DOI: 10.1021/ci100050t

Progress towards a public chemogenomic set for protein kinases and a call for contributions
journal, August 2017


Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
journal, October 2014


Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening
journal, June 2017

  • Ericksen, Spencer S.; Wu, Haozhen; Zhang, Huikun
  • Journal of Chemical Information and Modeling, Vol. 57, Issue 7
  • DOI: 10.1021/acs.jcim.7b00153

The Properties of Known Drugs. 1. Molecular Frameworks
journal, January 1996

  • Bemis, Guy W.; Murcko, Mark A.
  • Journal of Medicinal Chemistry, Vol. 39, Issue 15
  • DOI: 10.1021/jm9602928

Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses
journal, January 2014

  • Dančík, Vlado; Carrel, Hyman; Bodycombe, Nicole E.
  • Journal of Biomolecular Screening, Vol. 19, Issue 5
  • DOI: 10.1177/1087057113520226

Recent Advances in Scaffold Hopping: Miniperspective
journal, December 2016


Identification of Small Molecule Inhibitors That Block the Toxoplasma gondii Rhoptry Kinase ROP18
journal, January 2016

  • Simpson, Catherine; Jones, Nathaniel G.; Hull-Ryde, Emily A.
  • ACS Infectious Diseases, Vol. 2, Issue 3
  • DOI: 10.1021/acsinfecdis.5b00102

Docking and scoring in virtual screening for drug discovery: methods and applications
journal, November 2004

  • Kitchen, Douglas B.; Decornez, Hélène; Furr, John R.
  • Nature Reviews Drug Discovery, Vol. 3, Issue 11
  • DOI: 10.1038/nrd1549

Predicted Biological Activity of Purchasable Chemical Space
journal, December 2017

  • Irwin, John J.; Gaskins, Garrett; Sterling, Teague
  • Journal of Chemical Information and Modeling, Vol. 58, Issue 1
  • DOI: 10.1021/acs.jcim.7b00316

Aggregated Compound Biological Signatures Facilitate Phenotypic Drug Discovery and Target Elucidation
journal, September 2016

  • Cortes Cabrera, Alvaro; Lucena-Agell, Daniel; Redondo-Horcajo, Mariano
  • ACS Chemical Biology, Vol. 11, Issue 11
  • DOI: 10.1021/acschembio.6b00358

Model selection and estimation in regression with grouped variables
journal, February 2006


Chemogenomic Data Analysis: Prediction of Small-Molecule Targets and the Advent of Biological Fingerprints
journal, September 2007

  • Bender, Andreas; Young, Daniel; Jenkins, Jeremy
  • Combinatorial Chemistry & High Throughput Screening, Vol. 10, Issue 8
  • DOI: 10.2174/138620707782507313

Scaffold hopping
journal, December 2004

  • Böhm, Hans-Joachim; Flohr, Alexander; Stahl, Martin
  • Drug Discovery Today: Technologies, Vol. 1, Issue 3
  • DOI: 10.1016/j.ddtec.2004.10.009

Computational Methods in Drug Discovery
journal, December 2013

  • Sliwoski, Gregory; Kothiwale, Sandeepkumar; Meiler, Jens
  • Pharmacological Reviews, Vol. 66, Issue 1
  • DOI: 10.1124/pr.112.007336

Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization
journal, December 2013

  • Cobanoglu, Murat Can; Liu, Chang; Hu, Feizhuo
  • Journal of Chemical Information and Modeling, Vol. 53, Issue 12
  • DOI: 10.1021/ci400219z

Rethinking Molecular Similarity: Comparing Compounds on the Basis of Biological Activity
journal, May 2012

  • Petrone, Paula M.; Simms, Benjamin; Nigsch, Florian
  • ACS Chemical Biology, Vol. 7, Issue 8
  • DOI: 10.1021/cb3001028

Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors
journal, August 2017


Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation
journal, January 2010

  • Geppert, Hanna; Vogt, Martin; Bajorath, Jürgen
  • Journal of Chemical Information and Modeling, Vol. 50, Issue 2
  • DOI: 10.1021/ci900419k

Progress towards a public chemogenomic set for protein kinases and a call for contributions
text, January 2017

  • Susanne, Müller,; J., Zuercher, William; M., Andrews, David
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/7aj6-5547

Regularization Paths for Generalized Linear Models via Coordinate Descent
journal, January 2010

  • Friedman, Jerome; Hastie, Trevor; Tibshirani, Robert
  • Journal of Statistical Software, Vol. 33, Issue 1
  • DOI: 10.18637/jss.v033.i01

Circulating Proteomic Signature of Early Death in Heart Failure Patients with Reduced Ejection Fraction
journal, January 2019

  • Cuvelliez, Marie; Vandewalle, Vincent; Brunin, Maxime
  • SSRN Electronic Journal
  • DOI: 10.2139/ssrn.3396013

Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)
journal, January 2014


Active learning for computational chemogenomics
journal, March 2017

  • Reker, Daniel; Schneider, Petra; Schneider, Gisbert
  • Future Medicinal Chemistry, Vol. 9, Issue 4
  • DOI: 10.4155/fmc-2016-0197

Ligand Prediction for Orphan Targets Using Support Vector Machines and Various Target-Ligand Kernels Is Dominated by Nearest Neighbor Effects
journal, September 2009

  • Wassermann, Anne Mai; Geppert, Hanna; Bajorath, Jürgen
  • Journal of Chemical Information and Modeling, Vol. 49, Issue 10
  • DOI: 10.1021/ci9002624

Active learning for computational chemogenomics
text, January 2017


Introducing the ‘active search’ method for iterative virtual screening
journal, February 2015

  • Garnett, Roman; Gärtner, Thomas; Vogt, Martin
  • Journal of Computer-Aided Molecular Design, Vol. 29, Issue 4
  • DOI: 10.1007/s10822-015-9832-9

Chemogenomic Active Learning's Domain of Applicability on Small, Sparse qHTS Matrices: A Study Using Cytochrome P450 and Nuclear Hormone Receptor Families
journal, February 2018

  • Rakers, Christin; Najnin, Rifat Ara; Polash, Ahsan Habib
  • ChemMedChem, Vol. 13, Issue 6
  • DOI: 10.1002/cmdc.201700677

What do we know and when do we know it?
journal, February 2008


Simulation Analysis of Experimental Design Strategies for Screening Random Compounds as Potential New Drugs and Agrochemicals
journal, January 1995

  • Taylor, Robin
  • Journal of Chemical Information and Computer Sciences, Vol. 35, Issue 1
  • DOI: 10.1021/ci00023a009

Chemogenomic Active Learning's Domain of Applicability on Small, Sparse qHTS Matrices: A Study Using Cytochrome P450 and Nuclear Hormone Receptor Families
journal, February 2018

  • Rakers, Christin; Najnin, Rifat Ara; Polash, Ahsan Habib
  • ChemMedChem, Vol. 13, Issue 6
  • DOI: 10.1002/cmdc.201700677

What do we know and when do we know it?
journal, February 2008


Anticancer effects of marine compounds blocking the nuclear factor kappa B signaling pathway
journal, June 2022


Integrating virtual screening in lead discovery
journal, August 2004


Scaffold hopping
journal, December 2004

  • Böhm, Hans-Joachim; Flohr, Alexander; Stahl, Martin
  • Drug Discovery Today: Technologies, Vol. 1, Issue 3
  • DOI: 10.1016/j.ddtec.2004.10.009

Experimental Design Strategy: Weak Reinforcement Leads to Increased Hit Rates and Enhanced Chemical Diversity
journal, May 2015

  • Maciejewski, Mateusz; Wassermann, Anne Mai; Glick, Meir
  • Journal of Chemical Information and Modeling, Vol. 55, Issue 5
  • DOI: 10.1021/acs.jcim.5b00054

Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem’s Bioassay Repository
journal, January 2016

  • Helal, Kazi Yasin; Maciejewski, Mateusz; Gregori-Puigjané, Elisabet
  • Journal of Chemical Information and Modeling, Vol. 56, Issue 2
  • DOI: 10.1021/acs.jcim.5b00498

Data-Driven Derivation of an “Informer Compound Set” for Improved Selection of Active Compounds in High-Throughput Screening
journal, August 2016

  • Paricharak, Shardul; IJzerman, Adriaan P.; Jenkins, Jeremy L.
  • Journal of Chemical Information and Modeling, Vol. 56, Issue 9
  • DOI: 10.1021/acs.jcim.6b00244

Predicted Biological Activity of Purchasable Chemical Space
journal, December 2017

  • Irwin, John J.; Gaskins, Garrett; Sterling, Teague
  • Journal of Chemical Information and Modeling, Vol. 58, Issue 1
  • DOI: 10.1021/acs.jcim.7b00316

Discovering Highly Potent Molecules from an Initial Set of Inactives Using Iterative Screening
journal, August 2018

  • Cortés-Ciriano, Isidro; Firth, Nicholas C.; Bender, Andreas
  • Journal of Chemical Information and Modeling, Vol. 58, Issue 9
  • DOI: 10.1021/acs.jcim.8b00376

In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth
journal, September 2018


Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data
journal, February 2016

  • Paricharak, Shardul; IJzerman, Adriaan P.; Bender, Andreas
  • ACS Chemical Biology, Vol. 11, Issue 5
  • DOI: 10.1021/acschembio.6b00029

Aggregated Compound Biological Signatures Facilitate Phenotypic Drug Discovery and Target Elucidation
journal, September 2016

  • Cortes Cabrera, Alvaro; Lucena-Agell, Daniel; Redondo-Horcajo, Mariano
  • ACS Chemical Biology, Vol. 11, Issue 11
  • DOI: 10.1021/acschembio.6b00358

Extended-Connectivity Fingerprints
journal, April 2010

  • Rogers, David; Hahn, Mathew
  • Journal of Chemical Information and Modeling, Vol. 50, Issue 5
  • DOI: 10.1021/ci100050t

Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization
journal, December 2013

  • Cobanoglu, Murat Can; Liu, Chang; Hu, Feizhuo
  • Journal of Chemical Information and Modeling, Vol. 53, Issue 12
  • DOI: 10.1021/ci400219z

Using Information from Historical High-Throughput Screens to Predict Active Compounds
journal, June 2014

  • Riniker, Sereina; Wang, Yuan; Jenkins, Jeremy L.
  • Journal of Chemical Information and Modeling, Vol. 54, Issue 7
  • DOI: 10.1021/ci500190p

Ligand Prediction for Orphan Targets Using Support Vector Machines and Various Target-Ligand Kernels Is Dominated by Nearest Neighbor Effects
journal, September 2009

  • Wassermann, Anne Mai; Geppert, Hanna; Bajorath, Jürgen
  • Journal of Chemical Information and Modeling, Vol. 49, Issue 10
  • DOI: 10.1021/ci9002624

Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation
journal, January 2010

  • Geppert, Hanna; Vogt, Martin; Bajorath, Jürgen
  • Journal of Chemical Information and Modeling, Vol. 50, Issue 2
  • DOI: 10.1021/ci900419k

Do Structurally Similar Molecules Have Similar Biological Activity?
journal, September 2002

  • Martin, Yvonne C.; Kofron, James L.; Traphagen, Linda M.
  • Journal of Medicinal Chemistry, Vol. 45, Issue 19
  • DOI: 10.1021/jm020155c

The Properties of Known Drugs. 1. Molecular Frameworks
journal, January 1996

  • Bemis, Guy W.; Murcko, Mark A.
  • Journal of Medicinal Chemistry, Vol. 39, Issue 15
  • DOI: 10.1021/jm9602928

Docking and scoring in virtual screening for drug discovery: methods and applications
journal, November 2004

  • Kitchen, Douglas B.; Decornez, Hélène; Furr, John R.
  • Nature Reviews Drug Discovery, Vol. 3, Issue 11
  • DOI: 10.1038/nrd1549

Model selection and estimation in regression with grouped variables
journal, February 2006


Computational Methods in Drug Discovery
journal, December 2013

  • Sliwoski, Gregory; Kothiwale, Sandeepkumar; Meiler, Jens
  • Pharmacological Reviews, Vol. 66, Issue 1
  • DOI: 10.1124/pr.112.007336

Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses
journal, January 2014

  • Dančík, Vlado; Carrel, Hyman; Bodycombe, Nicole E.
  • Journal of Biomolecular Screening, Vol. 19, Issue 5
  • DOI: 10.1177/1087057113520226

Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors
journal, August 2017


Comprehensive characterization of the Published Kinase Inhibitor Set
text, January 2016

  • A., Tropsha,; M., Kunkel,; X. -P., Huang,
  • Nature Publishing Group
  • DOI: 10.17615/fnn8-qq87

Regularization Paths for Generalized Linear Models via Coordinate Descent
journal, January 2010

  • Friedman, Jerome; Hastie, Trevor; Tibshirani, Robert
  • Journal of Statistical Software, Vol. 33, Issue 1
  • DOI: 10.18637/jss.v033.i01

Chemogenomic Data Analysis: Prediction of Small-Molecule Targets and the Advent of Biological Fingerprints
journal, September 2007

  • Bender, Andreas; Young, Daniel; Jenkins, Jeremy
  • Combinatorial Chemistry & High Throughput Screening, Vol. 10, Issue 8
  • DOI: 10.2174/138620707782507313

Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)
journal, January 2014


Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
journal, October 2014


Active learning for computational chemogenomics
text, January 2017